About Us


About Us

A vertebral fracture occurs somewhere in the world every 22 seconds. Vertebral fractures play an important and little known role in back pain, and 100,000 patients suffer from it each year in France. However, only one in three vertebral fractures are clinically diagnosed [1].

Vexim is a specialist in the design and sale of minimally invasive solutions for the treatment of traumatic spine pathologies (low and high energy).


Based in Balma, near Toulouse, Vexim is an innovative company in the medical devices field, created and founded in 2006 by the investment fund Truffle Capital.


Since October 24th, 2017 Vexim is part of Stryker.

Our Mission: To provide both physicians and patients with the best in class treatment options.

Vexim has developed Masterflow™, an integrated system for the mixing and injection of orthopaedic cement, improving the accuracy of and optimising the surgical procedure.
Vexim sells orthopaedic cements: Cohesion® Bone Cement


From 2011, the figures speak for themselves on the success of Vexim:



And Vexim’s ambition does not stop there as its CEO, Vincent Gardès, seeks to capture 10% of the global market and attain a turnover of Eur 100 million within 5 years.


Vexim is backed financially by its shareholders: Truffle Capital, BPI (Banque Public d’Investissement), Kreaxi (formally Banexi Ventures Partners).


Spinal Fractures

Events & Education
  1. Silverman SL. The clinical consequences of vertebral compression fracture. Bone 1992;13 Suppl2:S27-31
  2. Products Legal Notices